Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C DeLuca

Showing results (141-150 of 385) with videos related to

Pageof 39
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|December 13, 2016
Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody diseaseMaciej Juryńczyk, George Tackley, Yazhuo Kong, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 6, 2019
A randomised double-blind placebo-controlled feasibility trial of flavonoid-rich cocoa for fatigue in people with relapsing and remitting multiple sclerosisShelly Coe, Jo Cossington, Johnny Collett, et al.
Nature Reviews. Neurology|March 28, 2018
The current role of MRI in differentiating multiple sclerosis from its imaging mimicsRuth Geraldes, Olga Ciccarelli, Frederik Barkhof, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2007
An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locusG C DeLuca, S V Ramagopalan, B M Herrera, et al.
Nature Reviews. Neurology|March 10, 2018
The current role of MRI in differentiating multiple sclerosis from its imaging mimicsRuth Geraldes, Olga Ciccarelli, Frederik Barkhof, et al.
Glia|September 5, 2015
Loss of galectin-3 decreases the number of immune cells in the subventricular zone and restores proliferation in a viral model of multiple sclerosisRachel E James, James Hillis, István Adorján, et al.
Neurology|August 21, 2020
Leading with inclusion during the COVID-19 pandemic: Stronger togetherLakshmi Warrior, Christine Y Kim, Daniel J Burdick, et al.
Angewandte Chemie (International Ed. in English)|March 5, 2024
"Off-Label Use" of the Siderophore Enterobactin Enables Targeted Imaging of Cancer with Radioactive Ti<sup>(IV)</sup>Angus J Koller, Owen Glaser, Molly C DeLuca, et al.
Molecular Medicine (Cambridge, Mass.)|May 22, 2013
TRPV1 gates tissue access and sustains pathogenicity in autoimmune encephalitisGeoffrey Paltser, Xue Jun Liu, Jason Yantha, et al.
Nature Neuroscience|June 21, 2022
Identification of early neurodegenerative pathways in progressive multiple sclerosisMax Kaufmann, Anna-Lena Schaupp, Rosa Sun, et al.
Pageof 39

Showing results (141-150 of 385) with videos related to

Sort By:
Pageof 39
Journal of Neurology, Neurosurgery, and Psychiatry|December 13, 2016
Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody diseaseMaciej Juryńczyk, George Tackley, Yazhuo Kong, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 6, 2019
A randomised double-blind placebo-controlled feasibility trial of flavonoid-rich cocoa for fatigue in people with relapsing and remitting multiple sclerosisShelly Coe, Jo Cossington, Johnny Collett, et al.
Nature Reviews. Neurology|March 28, 2018
The current role of MRI in differentiating multiple sclerosis from its imaging mimicsRuth Geraldes, Olga Ciccarelli, Frederik Barkhof, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 19, 2007
An extremes of outcome strategy provides evidence that multiple sclerosis severity is determined by alleles at the HLA-DRB1 locusG C DeLuca, S V Ramagopalan, B M Herrera, et al.
Nature Reviews. Neurology|March 10, 2018
The current role of MRI in differentiating multiple sclerosis from its imaging mimicsRuth Geraldes, Olga Ciccarelli, Frederik Barkhof, et al.
Glia|September 5, 2015
Loss of galectin-3 decreases the number of immune cells in the subventricular zone and restores proliferation in a viral model of multiple sclerosisRachel E James, James Hillis, István Adorján, et al.
Neurology|August 21, 2020
Leading with inclusion during the COVID-19 pandemic: Stronger togetherLakshmi Warrior, Christine Y Kim, Daniel J Burdick, et al.
Angewandte Chemie (International Ed. in English)|March 5, 2024
"Off-Label Use" of the Siderophore Enterobactin Enables Targeted Imaging of Cancer with Radioactive Ti<sup>(IV)</sup>Angus J Koller, Owen Glaser, Molly C DeLuca, et al.
Molecular Medicine (Cambridge, Mass.)|May 22, 2013
TRPV1 gates tissue access and sustains pathogenicity in autoimmune encephalitisGeoffrey Paltser, Xue Jun Liu, Jason Yantha, et al.
Nature Neuroscience|June 21, 2022
Identification of early neurodegenerative pathways in progressive multiple sclerosisMax Kaufmann, Anna-Lena Schaupp, Rosa Sun, et al.
Pageof 39